dPCR 시장 규모와 예측(2021-2031년) : 세계 및 지역별 점유율, 동향, 성장 기회 분석 리포트 - 제품별, 용도별, 최종사용자별
dPCR Market Size and Forecast 2021-2031, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product, Application, End user
상품코드:1938279
리서치사:The Insight Partners
발행일:2026년 01월
페이지 정보:영문 269 Pages
라이선스 & 가격 (부가세 별도)
한글목차
당사의 새로운 시장 조사 보고서 "dPCR 시장 예측(-2031년) - 세계 분석 - 제품별, 용도별, 최종사용자별"에 따르면 dPCR 시장은 2024년 75억 2,000만 달러에서 2031년까지 143억 4,000만 달러로 성장할 것으로 예측됩니다. 2025-2031년 연평균 9.9%의 연평균 복합 성장률(CAGR)을 보일 것으로 예측됩니다. dPCR 시장의 성장 요인으로는 고감도 및 고정밀 핵산 검출에 대한 수요, 임상 진단 및 맞춤형 의료의 적용 범위 확대, dPCR 기술 및 자동화의 발전 등을 꼽을 수 있습니다.
디지털 PCR(dPCR)은 DNA 또는 RNA 분자를 정밀하게 정량하는 첨단 분자생물학 기술입니다. 증폭량을 일괄적으로 측정하는 기존 PCR과 달리, dPCR은 샘플을 수천 개의 미세 반응으로 분할하여 각 분할을 개별적으로 분석합니다. 양성 반응의 수를 계산하여 표준 곡선을 사용하지 않고도 절대 정량이 가능하며, 저농도 또는 희귀한 유전자 표적의 검출에 높은 민감도를 발휘합니다. dPCR은 임상 진단, 감염 감지, 종양학, 법의학, 수사 분야에서 널리 활용되고 있으며, 기존 PCR로 분석하기 어려운 열화된 시료나 복잡한 시료의 분석에서도 뛰어난 정확도와 재현성을 제공합니다.
북미의 dPCR 시장은 미국, 캐나다, 멕시코로 구분됩니다. 미국 디지털 PCR 시장의 성장은 주로 다양한 의료 분야에서 정밀하고 민감한 진단 툴에 대한 수요 증가에 기인합니다. 미국 질병통제예방센터(CDC)에 따르면 COVID-19를 포함한 감염병의 확산으로 인해 첨단 검사 기법의 필요성이 지속적으로 증가하고 있으며, 진단 검사 건수는 2022년 2억 건에서 2023년 약 2억 5,000만 건으로 급증할 것으로 예상하고 있습니다. CDC가 고품질 진단, 특히 바이러스 RNA 및 유전자 변이 검출에 대한 지속적인 수요를 예측하는 가운데, dPCR 기술은 높은 특이성과 민감도로 인해 주목을 받고 있습니다. 또한 신제품 개발도 시장 성장에 기여하고 있습니다. 예를 들어 2023년 미국 식품의약국(FDA)은 종양학 분야에 대한 여러 가지 새로운 dPCR 분석법을 승인하여 액체생검 기술로 암을 조기에 발견할 수 있도록 했습니다. 또한 미국 국립암연구소의 연구에 따르면 2024년까지 약 190만 건의 새로운 암이 진단될 것으로 예상되며, 종양학 분야에서 정확한 분자진단에 대한 수요가 증가하고 있습니다.
미생물 및 공중보건 감시 분야로의 확장으로 미래 시장 기회 제공
미생물 및 공중보건 감시 분야로의 확대는 감염병 감시 및 미생물 진단에 대한 dPCR 적용 확대의 유망한 기회가 될 수 있습니다. 2024년 6월, QIAGEN은 QIAcuity 플랫폼에서 뎅기 바이러스(1-4형), 원숭이두창(I 및 II 계통), 말라리아 원충, 항생제 내성 유전자와 같은 병원균을 대상으로 하는 35종의 새로운 습식 실험실 테스트 미생물 DNA 검출 분석법을 발표했습니다. 발표했습니다. 이러한 분석은 병원체 정량의 정확성과 민감도를 향상시켜 공중보건 연구소가 발병 감시, 내성 추적 및 신속한 대응을 할 수 있도록 도와줍니다. QIAGEN의 GeneGlobe 포털을 통해 이용할 수 있으며, 폭넓은 접근성과 사용 편의성을 제공합니다. dPCR이 표준 곡선 없이 절대 정량을 제공하는 능력은 변동성을 줄이고 실험실 간 비교 가능성을 향상시켜 협력적 모니터링 프로그램에 매우 중요합니다. "The Journal of Applied Laboratory Medicine 저널의 리뷰에 따르면 dPCR의 임상 응용 분야에는 미생물학 및 감염성 질환 진단이 포함되며, 검증된 미생물 분석 포트폴리오가 확대됨에 따라 임상 및 공중보건 분야에서의 도입 장벽이 낮아지고 있다고 합니다. 각국 정부와 국제기구가 유전체 역학을 우선순위에 두고 있는 가운데, 이러한 발전은 dPCR이 전 세계 보건 감시 및 발병 대응에 필수적인 툴이 될 수 있는 강력한 기회를 창출하고 있습니다.
목차
제1장 도입
제2장 개요
제3장 조사 방법
제4장 dPCR 시장 구도
제5장 dPCR 시장 - 주요 업계 동향
제6장 dPCR 시장 - 세계 시장 분석
제7장 세계의 dPCR 시장 - 매출과 예측 - 제품별
제8장 세계의 dPCR 시장 - 2031년까지의 매출과 예측 - 용도별
제9장 세계의 dPCR 시장 - 2031년까지의 매출과 예측 - 최종사용자별
제10장 dPCR 시장 - 지역 분석
제11장 dPCR 시장의 업계 상황
제12장 기업 개요
제13장 부록
KSA
영문 목차
영문목차
According to our new research study on "dPCR Market Forecast to 2031 -Global Analysis - by Product, Application, and End User," the market is anticipated to grow from US$7.52 billion in 2024 to US$14.34 billion by 2031; the market is expected to register a CAGR of 9.9% from 2025 to 2031. The dPCR Market growth is attributed to the demand for highly sensitive and accurate nucleic acid detection, expanding applications in clinical diagnostics and personalized medicine, and rising advancements in dPCR technology and automation.
Digital PCR (dPCR) is an advanced molecular biology technique used to precisely quantify DNA or RNA molecules. Unlike traditional PCR, which measures amplification in bulk, dPCR partitions a sample into thousands of tiny reactions, with each partition analyzed individually. By counting the number of positive reactions, it provides absolute quantification without the need for standard curves, making it highly sensitive for detecting low-abundance or rare genetic targets. dPCR is widely used in clinical diagnostics, infectious disease detection, oncology, forensics, and research, offering superior precision, reproducibility, and the ability to analyze degraded or complex samples that traditional PCR struggles with.
The dPCR Market in North America is segmented into the US, Canada, and Mexico. The growth of the US digital PCR Market is largely attributed to the increasing demand for precise and sensitive diagnostic tools in various medical fields. According to the Centers for Disease Control and Prevention (CDC), the prevalence of infectious diseases, including COVID-19, continues to drive the need for advanced testing methods, with diagnostic test volumes soaring from 200 million in 2022 to an estimated 250 million in 2023. As the CDC projects an enduring need for high-quality diagnostics, particularly in the detection of viral RNA and genetic mutations, dPCR technology has gained prominence for its enhanced specificity and sensitivity. Additionally, new product developments have contributed to market growth; for instance, in 2023, the US Food and Drug Administration (FDA) approved several novel dPCR assays for oncology, enabling earlier detection of cancers through liquid biopsy techniques. Furthermore, a study by the National Cancer Institute reported that, by 2024, ~1.9 million new cancer cases are expected to be diagnosed, fueling the demand for accurate molecular diagnostics in oncology.
Expansion into Microbial and Public Health Surveillance to Provide Market Opportunities in Future
Expansion into microbial and public health surveillance is a promising opportunity that lies in the expansion of dPCR into infectious disease surveillance and microbial diagnostics. In June 2024, QIAGEN launched 35 new wet-lab-tested microbial DNA detection assays on its QIAcuity platform, targeting pathogens including Dengue virus (serotypes 1-4), Monkeypox (clades I & II), malaria parasites, and antibiotic-resistance genes. These assays enhance the precision and sensitivity of pathogen quantification, enabling public-health labs to monitor outbreaks, track resistance, and respond more swiftly. These assays are available via QIAGEN's GeneGlobe portal, promoting broad access and ease of use. The ability of dPCR to provide absolute quantification without standard curves reduces variability and improves comparability between labs, which is crucial for coordinated surveillance programs. According to a review in The Journal of Applied Laboratory Medicine, clinical applications of dPCR include microbiology and infectious disease diagnostics, and the increasing portfolio of validated microbial assays lowers the barrier to clinical and public health adoption. As governments and international agencies increasingly prioritize genomic epidemiology, these developments create a strong opportunity for dPCR to become an integral tool in global health surveillance and outbreak response.
World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), American Chemical Society Publications, The U.S. Centers for Medicare & Medicaid Services (CMS), US Department of Health & Human Services, Public Health Agency of Canada (PHAC), French National Institute of Health and Medical Research (INSERM), Italian National Institute of Health (ISS), The Korean Journal of Internal Medicine, the Saudi Press Agency (SPA), UAE Ministry of Health and Prevention (MOHAP) are among the primary and secondary sources referred to while preparing the dPCR Market report.
Table Of Contents
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. dPCR Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Global PEST Analysis
5. dPCR Market - Key Industry Dynamics
5.1 Market Drivers
5.1.1 Increasing Demand for Highly Sensitive and Accurate Nucleic Acid Detection
5.1.2 Expanding Applications in Clinical Diagnostics and Personalized Medicine
5.1.3 Rising Advancements in dPCR Technology and Automation
5.2 Market Restraints
5.2.1 High Cost of Instrumentation and Consumables
5.2.2 Lack of Standardization and Regulatory Guidance
5.2.3 Technical Complexity and Need for Specialized Expertise
5.3 Market Opportunities
5.3.1 Growth in Cell & Gene Therapy Quality Control
5.3.2 Expansion into Microbial and Public Health Surveillance
5.3.3 Noninvasive Prenatal Testing (NIPT) and Reproductive Genetics
5.4 Future Trends
5.4.1 Miniaturization and Portability of dPCR Systems
5.4.2 Increased Adoption in Liquid Biopsy for Cancer Diagnostics
5.4.3 Integration with Automation and Bioinformatics for Enhanced Workflow
5.5 Impact Analysis:
6. dPCR Market - Global Market Analysis
6.1 dPCR Market Revenue (US$ Mn), 2021 - 2031
7. Global dPCR Market - Revenue and Forecast to 2031 - by Product
7.1 Overview
7.2 dPCR Market Revenue Share, by Product, 2021 & 2031(%)
7.3 Reagents & Consumables
7.3.1 Overview
7.3.2 Reagents & Consumables: dPCR Market - Revenue and Forecast to 2031 (US$ Million)
7.4 Instruments
7.4.1 Overview
7.4.2 Instruments: dPCR Market - Revenue and Forecast to 2031 (US$ Million)
7.5 Software & Services
7.5.1 Overview
7.5.2 Software & Services: dPCR Market - Revenue and Forecast to 2031 (US$ Million)
8. Global dPCR Market - Revenue and Forecast to 2031 - by Application
8.1 Overview
8.2 dPCR Market Revenue Share, by Application, 2021 & 2031(%)
8.3 Research Application
8.3.1 Overview
8.3.2 Research Application: dPCR Market - Revenue and Forecast to 2031 (US$ Million)
8.4 Clinical Application
8.4.1 Overview
8.4.2 Clinical Application: dPCR Market - Revenue and Forecast to 2031 (US$ Million)
8.4.2.1 dPCR Market, by Clinical Application, 2021-2031 (US$ Million)
8.5 Forensic Application
8.5.1 Overview
8.5.2 Forensic Application: dPCR Market - Revenue and Forecast to 2031 (US$ Million)
9. Global dPCR Market - Revenue and Forecast to 2031 - by End-User
9.1 Overview
9.2 dPCR Market Revenue Share, by End-User, 2021 & 2031(%)
9.3 Hospitals and Diagnostic Centers
9.3.1 Overview
9.3.2 Hospitals and Diagnostic Centers: dPCR Market - Revenue and Forecast to 2031 (US$ Million)
9.4 Pharmaceutical and Biotechnology Companies
9.4.1 Overview
9.4.2 Pharmaceutical and Biotechnology Companies: dPCR Market - Revenue and Forecast to 2031 (US$ Million)
9.5 Research Laboratories and Academic Institutes
9.5.1 Overview
9.5.2 Research Laboratories and Academic Institutes: dPCR Market - Revenue and Forecast to 2031 (US$ Million)
9.6 Forensic Laboratories
9.6.1 Overview
9.6.2 Forensic Laboratories: dPCR Market - Revenue and Forecast to 2031 (US$ Million)
9.7 Clinical Research Organizations
9.7.1 Overview
9.7.2 Clinical Research Organizations: dPCR Market - Revenue and Forecast to 2031 (US$ Million)
10. dPCR Market - Geographical Analysis
10.1 North America dPCR Market, Revenue and Forecast To 2031
10.1.1 Overview
10.1.2 North America dPCR Market Revenue and Forecast to 2031 (US$ Mn)
10.1.3 North America: dPCR Market, by Product, 2021-2031 (US$ Million)
10.1.4 North America: dPCR Market, by Application, 2021-2031 (US$ Million)
10.1.4.1 North America: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.1.5 North America: dPCR Market, by End-User, 2021-2031 (US$ Million)
10.1.5.1 North America dPCR Market, by Country
10.1.5.2 US
10.1.5.2.1 US dPCR Market Revenue and Forecast to 2031 (US$ Mn)
10.1.5.2.2 US: dPCR Market, by Product, 2021-2031 (US$ Million)
10.1.5.2.3 US: dPCR Market, by Application, 2021-2031 (US$ Million)
10.1.5.2.4.1 US: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.1.5.2.5 US: dPCR Market, by End-User, 2021-2031 (US$ Million)
10.1.5.3 Canada
10.1.5.3.1 Canada dPCR Market Revenue and Forecast to 2031 (US$ Mn)
10.1.5.3.2 Canada: dPCR Market, by Product, 2021-2031 (US$ Million)
10.1.5.3.3 Canada: dPCR Market, by Application, 2021-2031 (US$ Million)
10.1.5.3.4.1 Canada: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.1.5.3.5 Canada: dPCR Market, by End-User, 2021-2031 (US$ Million)
10.1.5.4 Mexico
10.1.5.4.1 Mexico dPCR Market Revenue and Forecast to 2031 (US$ Mn)
10.1.5.4.2 Mexico: dPCR Market, by Product, 2021-2031 (US$ Million)
10.1.5.4.3 Mexico: dPCR Market, by Application, 2021-2031 (US$ Million)
10.1.5.4.3.1 Mexico: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.1.5.4.4 Mexico: dPCR Market, by End-User, 2021-2031 (US$ Million)
10.2 Europe dPCR Market, Revenue and Forecast to 2031
10.2.1 Overview
10.2.2 Europe dPCR Market Revenue and Forecast to 2031 (US$ Mn)
10.2.3 Europe: dPCR Market, by Product, 2021-2031 (US$ Million)
10.2.4 Europe: dPCR Market, by Application, 2021-2031 (US$ Million)
10.2.4.1 Europe: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.2.5 Europe: dPCR Market, by End-User, 2021-2031 (US$ Million)
10.2.5.1 Europe dPCR Market, by Country
10.2.5.2 UK
10.2.5.2.1 UK dPCR Market Revenue and Forecast to 2031 (US$ Mn)
10.2.5.2.2 UK: dPCR Market, by Product, 2021-2031 (US$ Million)
10.2.5.2.3 UK: dPCR Market, by Application, 2021-2031 (US$ Million)
10.2.5.2.3.1 UK: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.2.5.2.4 UK: dPCR Market, by End-User, 2021-2031 (US$ Million)
10.2.5.3 Germany
10.2.5.3.1 Germany dPCR Market Revenue and Forecast to 2031 (US$ Mn)
10.2.5.3.2 Germany: dPCR Market, by Product, 2021-2031 (US$ Million)
10.2.5.3.3 Germany: dPCR Market, by Application, 2021-2031 (US$ Million)
10.2.5.3.3.1 Germany: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.2.5.3.4 Germany: dPCR Market, by End-User, 2021-2031 (US$ Million)
10.2.5.4 France
10.2.5.4.1 France dPCR Market Revenue and Forecast to 2031 (US$ Mn)
10.2.5.4.2 France: dPCR Market, by Product, 2021-2031 (US$ Million)
10.2.5.4.3 France: dPCR Market, by Application, 2021-2031 (US$ Million)
10.2.5.4.3.1 France: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.2.5.4.4 France: dPCR Market, by End-User, 2021-2031 (US$ Million)
10.2.5.5 Italy
10.2.5.5.1 Italy dPCR Market Revenue and Forecast to 2031 (US$ Mn)
10.2.5.5.2 Italy: dPCR Market, by Product, 2021-2031 (US$ Million)
10.2.5.5.3 Italy: dPCR Market, by Application, 2021-2031 (US$ Million)
10.2.5.5.3.1 Italy: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.2.5.5.4 Italy: dPCR Market, by End-User, 2021-2031 (US$ Million)
10.2.5.6 Spain
10.2.5.6.1 Spain dPCR Market Revenue and Forecast to 2031 (US$ Mn)
10.2.5.6.2 Spain: dPCR Market, by Product, 2021-2031 (US$ Million)
10.2.5.6.3 Spain: dPCR Market, by Application, 2021-2031 (US$ Million)
10.2.5.6.3.1 Spain: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.2.5.3.5 Spain: dPCR Market, by End-User, 2021-2031 (US$ Million)
10.2.5.7 Rest of Europe
10.2.5.7.1 Rest of Europe dPCR Market Revenue and Forecast to 2031 (US$ Mn)
10.2.5.7.2 Rest of Europe: dPCR Market, by Product, 2021-2031 (US$ Million)
10.2.5.7.3 Rest of Europe: dPCR Market, by Application, 2021-2031 (US$ Million)
10.2.5.7.3.1 Rest of Europe: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.2.5.7.4 Rest of Europe: dPCR Market, by End-User, 2021-2031 (US$ Million)
10.3 Asia Pacific dPCR Market, Revenue and Forecast to 2031
10.3.1 Overview
10.3.2 Asia Pacific dPCR Market Revenue and Forecast to 2031 (US$ Mn)
10.3.3 Asia Pacific: dPCR Market, by Product, 2021-2031 (US$ Million)
10.3.4 Asia Pacific: dPCR Market, by Application, 2021-2031 (US$ Million)
10.3.4.1 Asia Pacific: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.3.5 Asia Pacific: dPCR Market, by End-User, 2021-2031 (US$ Million)
10.3.5.1 Asia Pacific dPCR Market, by Country
10.3.5.2 China
10.3.5.2.1 China dPCR Market Revenue and Forecast to 2031 (US$ Mn)
10.3.5.2.2 China: dPCR Market, by Product, 2021-2031 (US$ Million)
10.3.5.2.3 China: dPCR Market, by Application, 2021-2031 (US$ Million)
10.3.5.2.3.1 China: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.3.5.2.4 China: dPCR Market, by End-User, 2021-2031 (US$ Million)
10.3.5.3 Japan
10.3.5.3.1 Japan dPCR Market Revenue and Forecast to 2031 (US$ Mn)
10.3.5.3.2 Japan: dPCR Market, by Product, 2021-2031 (US$ Million)
10.3.5.3.3 Japan: dPCR Market, by Application, 2021-2031 (US$ Million)
10.3.5.3.3.1 Japan: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.3.5.3.4 Japan: dPCR Market, by End-User, 2021-2031 (US$ Million)
10.3.5.4 India
10.3.5.4.1 India dPCR Market Revenue and Forecast to 2031 (US$ Mn)
10.3.5.4.2 India: dPCR Market, by Product, 2021-2031 (US$ Million)
10.3.5.4.3 India: dPCR Market, by Application, 2021-2031 (US$ Million)
10.3.5.4.3.1 India: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.3.5.4.4 India: dPCR Market, by End-User, 2021-2031 (US$ Million)
10.3.5.5 Australia
10.3.5.5.1 Australia dPCR Market Revenue and Forecast to 2031 (US$ Mn)
10.3.5.5.2 Australia: dPCR Market, by Product, 2021-2031 (US$ Million)
10.3.5.5.3 Australia: dPCR Market, by Application, 2021-2031 (US$ Million)
10.3.5.5.3.1 Australia: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.3.5.5.4 Australia: dPCR Market, by End-User, 2021-2031 (US$ Million)
10.3.5.6 South Korea
10.3.5.6.1 South Korea dPCR Market Revenue and Forecast to 2031 (US$ Mn)
10.3.5.6.2 South Korea: dPCR Market, by Product, 2021-2031 (US$ Million)
10.3.5.6.3 South Korea: dPCR Market, by Application, 2021-2031 (US$ Million)
10.3.5.6.3.1 South Korea: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.3.5.6.4 South Korea: dPCR Market, by End-User, 2021-2031 (US$ Million)
10.3.5.7 Rest of Asia Pacific
10.3.5.7.1 Rest of Asia Pacific dPCR Market Revenue and Forecast to 2031 (US$ Mn)
10.3.5.7.2 Rest of Asia Pacific: dPCR Market, by Product, 2021-2031 (US$ Million)
10.3.5.7.3 Rest of Asia Pacific: dPCR Market, by Application, 2021-2031 (US$ Million)
10.3.5.7.3.1 Rest of Asia Pacific: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.3.5.7.4 Rest of Asia Pacific: dPCR Market, by End-User, 2021-2031 (US$ Million)
10.4 Middle East & Africa dPCR Market, Revenue and Forecast to 2031
10.4.1 Overview
10.4.2 Middle East & Africa dPCR Market Revenue and Forecast to 2031 (US$ Mn)
10.4.3 Middle East & Africa: dPCR Market, by Product, 2021-2031 (US$ Million)
10.4.4 Middle East & Africa: dPCR Market, by Application, 2021-2031 (US$ Million)
10.4.4.1 Middle East & Africa: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.4.5 Middle East & Africa: dPCR Market, by End-User, 2021-2031 (US$ Million)
10.3.5.1 Middle East & Africa dPCR Market, by Country
10.3.5.2 Saudi Arabia
10.3.5.2.1 Saudi Arabia dPCR Market Revenue and Forecast to 2031 (US$ Mn)
10.3.5.2.2 Saudi Arabia: dPCR Market, by Product, 2021-2031 (US$ Million)
10.3.5.2.3 Saudi Arabia: dPCR Market, by Application, 2021-2031 (US$ Million)
10.3.5.2.3.1 Saudi Arabia: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.3.5.2.4 Saudi Arabia: dPCR Market, by End-User, 2021-2031 (US$ Million)
10.3.5.3 UAE
10.3.5.3.1 UAE dPCR Market Revenue and Forecast to 2031 (US$ Mn)
10.3.5.3.2 UAE: dPCR Market, by Product, 2021-2031 (US$ Million)
10.3.5.3.3 UAE: dPCR Market, by Application, 2021-2031 (US$ Million)
10.3.5.3.3.1 UAE: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.3.5.3.5 UAE: dPCR Market, by End-User, 2021-2031 (US$ Million)
10.3.5.4 South Africa
10.3.5.4.1 South Africa dPCR Market Revenue and Forecast to 2031 (US$ Mn)
10.3.5.4.2 South Africa: dPCR Market, by Product, 2021-2031 (US$ Million)
10.3.5.4.3 South Africa: dPCR Market, by Application, 2021-2031 (US$ Million)
10.3.5.4.3.1 South Africa: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.3.5.4.4 South Africa: dPCR Market, by End-User, 2021-2031 (US$ Million)
10.3.5.5 Rest of Middle East & Africa
10.3.5.5.1 Rest of Middle East & Africa dPCR Market Revenue and Forecast to 2031 (US$ Mn)
10.3.5.5.2 Rest of Middle East & Africa: dPCR Market, by Product, 2021-2031 (US$ Million)
10.3.5.5.3 Rest of Middle East & Africa: dPCR Market, by Application, 2021-2031 (US$ Million)
10.3.5.5.3.1 Rest of Middle East & Africa: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.3.5.5.4 Rest of Middle East & Africa: dPCR Market, by End-User, 2021-2031 (US$ Million)
10.5 South & Central America dPCR Market, Revenue and Forecast to 2031
10.5.1 Overview
10.5.2 South & Central America dPCR Market Revenue and Forecast to 2031 (US$ Mn)
10.5.3 South & Central America: dPCR Market, by Product, 2021-2031 (US$ Million)
10.5.4 South & Central America: dPCR Market, by Application, 2021-2031 (US$ Million)
10.5.4.1 South & Central America: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.5.5 South & Central America: dPCR Market, by End-User, 2021-2031 (US$ Million)
10.5.5.1 South & Central America dPCR Market, by Country
10.5.5.2 Brazil
10.5.5.2.1 Brazil dPCR Market Revenue and Forecast to 2031 (US$ Mn)
10.5.5.2.2 Brazil: dPCR Market, by Product, 2021-2031 (US$ Million)
10.5.5.2.3 Brazil: dPCR Market, by Application, 2021-2031 (US$ Million)
10.5.5.2.3.1 Brazil: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.5.5.2.4 Brazil: dPCR Market, by End-User, 2021-2031 (US$ Million)
10.5.5.3 Argentina
10.5.5.3.1 Argentina dPCR Market Revenue and Forecast to 2031 (US$ Mn)
10.5.5.3.2 Argentina: dPCR Market, by Product, 2021-2031 (US$ Million)
10.5.5.3.3 Argentina: dPCR Market, by Application, 2021-2031 (US$ Million)
10.5.5.3.3.1 Argentina: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.5.5.3.4 Argentina: dPCR Market, by End-User, 2021-2031 (US$ Million)
10.5.5.4 Rest of South & Central America
10.5.5.4.1 Rest of South & Central America dPCR Market Revenue and Forecast to 2031 (US$ Mn)
10.5.5.4.2 Rest of South & Central America: dPCR Market, by Product, 2021-2031 (US$ Million)
10.5.5.4.3 Rest of South & Central America: dPCR Market, by Application, 2021-2031 (US$ Million)
10.5.5.4.3.1 Rest of South & Central America: dPCR Market, for Clinical Application by Application, 2021 - 2031 (US$ Million)
10.5.5.4.4 Rest of South & Central America: dPCR Market, by End-User, 2021-2031 (US$ Million)
